PharmOncology

← PharmOncology16. Sept. · 17 Min.

Sequencing agents in HER2 mutant lung cancer

Sequencing agents in HER2 mutant lung cancer16. Sept.17 Min.

<p>How I think agents should be sequenced in HER2 mutant lung cancer.</p><p><br></p><p>Case report on zongertinib upregulating HER2 receptors: https://pmc.ncbi.nlm.nih.gov/articles/PMC12964209/</p>